Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.26M Sell
35,911
-10,029
-22% -$915K 0.7% 35
2026
Q1
$4.72M Sell
45,940
-8,689
-16% -$981K 1.04% 31
2025
Q4
$6.84M Sell
54,629
-55,579
-50% -$7.08M 1.64% 25
2025
Q3
$14.8M Buy
110,208
+1,780
+2% +$234K 3.44% 6
2025
Q2
$14.7M Buy
108,428
+54,972
+103% +$7.25M 3.72% 5
2025
Q1
$7.09M Sell
53,456
-1,633
-3% -$208K 1.96% 25
2024
Q4
$6.23M Buy
+55,089
New +$6.37M 1.67% 25

Other funds holding ABT

Paradiem's ABT Position: Q2 2026 in Review

Paradiem reduced its Abbott (ABT) stake by 22% in Q2 2026, selling an estimated $915K and leaving 35,911 shares worth $3.26M. The position accounts for 0.7% of the portfolio, ranked #35.

Paradiem first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.8M in Q3 2025. 1,385 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Paradiem held 35,911 shares of Abbott worth $3.26M as of Q2 2026.
  • Paradiem sold 10,029 Abbott shares in Q2 2026, an estimated $915K.
  • Abbott made up 0.7% of Paradiem's portfolio in Q2 2026, its #35 holding.
  • Paradiem first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Paradiem's Abbott position peaked at $14.8M in Q3 2025.
  • 1,385 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Paradiem's 13F filing for Q2 2026, filed 14 Jul 2026.